Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 183 for lung disease

Edit search filters
  1. A Study of Patient Reported Outcomes and Use of Self-Efficacy in the Management of Chronic Fibrotic Interstitial Lung Disease

    Rochester, MN

  2. Screening for High Frequency Malignant Disease

    Rochester, MN, Eau Claire, WI, La Crosse, WI

  3. FilmArray Respiratory Pathogen Panel (FARP) in Detecting Pathogens in ILD Patients with Worsening Lung Function

    Rochester, MN

  4. A Study of Interstitial Lung Disease Relating to the Development of Fibrosis in the Lungs

    Rochester, MN

  5. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography

    Rochester, MN

  6. A Study to Identify Biomarkers in Patients with Rheumatoid Arthritis and Interstitial Lung Disease

    Rochester, MN

  7. Creation of a Longitudinal Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

    Rochester, MN

  8. A Study to Analyze Isolation, Activation and Expansion of Mutation Reactive T-cells

    Rochester, MN

  9. A Study of the Performance of Genome Sequencing as a Clinical Test to Identify Multifocal Lung Cancers for Treatment, versus Advanced Metastatic Disease

    Rochester, MN

  10. A Study of the Effectiveness of Palliative Care Consultation for Patients with Advanced Lung Disease

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer